Creative Medical Health announced today filing of intellectual property covering the utilization of its proprietary mesenchymal stem cell-based product for treatment for autoimmune diseases, with multiple sclerosis being the first disease in which the product will be clinically assessed.
from Content Keyword RSS http://ift.tt/1Fbuhze
via IFTTT
from Content Keyword RSS http://ift.tt/1Fbuhze
via IFTTT
No comments:
Post a Comment